Co-GP / Platform:A family office could deploy into the Philadelphia life sciences market by partnering with established operators through co-GP or JV equity arrangements to share in the promote.

Co-GP / Platform:A family office could deploy into the Bay Area life science market by backing a sponsor or operator at the GP level, sharing in the promote and aligning interests to capitalize on future demand.

Co-GP / Platform:A family office could deploy into the Raleigh life sciences market by backing a sponsor or operator through co-GP or JV equity arrangements to share in the promote.

Co-GP / Platform:A family office could back a specialized life sciences operator in Greater Boston through a co-GP or JV equity structure to share in the promote and enhance returns.

Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the Puget Sound life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor/operator at the GP level, particularly in light of the significant capital raised by companies like ArsenalBio and Caresyntax.

Co-GP / Platform:A family office could deploy into the New York life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a robust pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the Philadelphia life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a repeatable pipeline of deals.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor like Trammell Crow or Alexandria Real Estate Equities at the GP level to share in the promote and access a repeatable pipeline of life sciences developments.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, participating in co-GP or JV equity arrangements to share in the promote.

Co-GP / Platform:A family office could deploy into the Denver life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of development projects.

Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of innovative projects.

Co-GP / Platform:A family office could deploy into the Seattle life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and benefiting from a strong pipeline of developments.

Co-GP / Platform:A family office could deploy into this market by partnering with established operators like DEVCO or SJP Properties to co-GP on significant life sciences developments.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and aligning interests as developers offload assets.

Co-GP / Platform:A family office could deploy into the Raleigh-Durham life sciences market by backing a sponsor like Longfellow Real Estate or Trinity Capital Advisors at the GP level to share in the promote and access a pipeline of new developments.

Co-GP / Platform:A family office could deploy into the Bay Area life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from a strong deal flow.

Co-GP / Platform:A family office could deploy into the Denver life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the New York City life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the San Francisco life science market by backing a sponsor/operator at the GP level, sharing in the promote and benefiting from a robust pipeline of new developments.

Co-GP / Platform:A family office could deploy into the Philadelphia life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the Boston life science market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity structures.

Co-GP / Platform:A family office could deploy into the U.S. life sciences market by backing a sponsor or operator at the GP level, capitalizing on the growing demand for life science facilities adjacent to healthcare ecosystems.